Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction

British Journal of Ophthalmology

Volumn 93, Issue 8, 2009, Pages 1020-1026

  Kohno, R I ^a   Hata, Y ^a   Kawahara, S ^a   Kita, T ^a   Arita, R ^a   Mochizuki, Y ^a   Aiello, L P ^b,c   Ishibashi, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN GEL; COLLAGEN TYPE 1; GLIAL FIBRILLARY ACIDIC PROTEIN; PARAFORMALDEHYDE; TRANSFORMING GROWTH FACTOR BETA2;

AGED; ANIMAL CELL; ARTICLE; CELL COMPOSITION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPIRETINAL MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALOCYTE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MUSCLE FIBER CONTRACTION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VITREOUS BODY; WESTERN BLOTTING;

ACTINS; AGED; ANIMALS; ASTROCYTES; CATTLE; CELLS, CULTURED; COLLAGEN; EPIRETINAL MEMBRANE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA2; VITREOUS BODY;

EID: 68049109127     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.155069     Document Type: Article

References (25)

1. Foos RY. Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci 1977;16:416-422
2. Kampik A, Green WR, Michels RG, et al. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980;90:797-809. (Pubitemid 11199133)
3. Smiddy WE, Michels RG, Green WR. Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina 1990;10:288-296
4. Kishi S, Shimizu K. Oval defect in detached posterior hyaloid membrane in idiopathic preretinal macular fibrosis. Am J Ophthalmol 1994;118:451-456 (Pubitemid 24307212)
5. Sebag J, ed. Surgical anatomy of vitreous and the vitreo-retinal interface. Philadelphia: JB Lippincott, 1994.
6. Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreoretinal disease. Graefes Arch Clin Exp Ophthalmol 2004;242:690-698 (Pubitemid 39242846)
7. Chu TG, Lopez PF, Cano MR, et al. Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology 1996;103:315-322
8. Sebag J, Gupta P, Rosen RR, et al. Macular holes and macular pucker: the role of vitreoschisis as imaged by optical coherence tomography/scanning laser ophthalmoscopy. Trans Am Ophthalmol Soc 2007;105:121-9; discusion 129-131 (Pubitemid 352031802)
9. Hamburg A. Some investigations on the cells of the vitreous body. Ophthalmologica 1959;138:81-107.
10. Sebag J, ed. The vitreous: structure, function, and pathology. New York: Springer, 1989.
11. Hirayama K, Hata Y, Noda Y, et al. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Invest Ophthalmol Vis Sci 2004;45:3896-3903 (Pubitemid 39411139)
12. Kawahara S, Hata Y, Kita T, et al. Potent Inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. Diabetes 2008.
13. Kita T, Hata Y, Kano K, et al. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 2007;56:231-238 (Pubitemid 46263122)
14. Kita T, Hata Y, Arita R, et al. Role of TGF-{beta} in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci USA 2008.
15. Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol 2008;246:329-332
16. Noda Y, Hata Y, Hisatomi T, et al. Functional properties of hyalocytes under PDGF-rich conditions. Invest Ophthalmol Vis Sci 2004;45:2107-2114 (Pubitemid 38902577)
17. Miura M, Hata Y, Hirayama K, et al. Critical role of the Rho-kinase pathway in TGFbeta2- dependent collagen gel contraction by retinal pigment epithelial cells. Exp Eye Res 2006;82:849-859 (Pubitemid 43170885)
18. Roth AM, Foos RY. Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans Am Acad Ophthalmol Otolaryngol 1971;75:1047-1058
19. Smiddy WE, Green WR, Michels RG, et al. Ultrastructural studies of vitreomacular traction syndrome. Am J Ophthalmol 1989;107:177-185
20. Sebag J, ed. The vitreous. St Louis: Mosby, 1992.
21. Grosche J, Hartig W, Reichenbach A. Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl-2 protooncogene protein by Muller (glial) cells in retinal light damage of rats. Neurosci Lett 1995;185:119-122
22. Nishitsuka K, Kashiwagi Y, Tojo N, et al. Hyaluronan production regulation from porcine hyalocyte cell line by cytokines. Exp Eye Res 2007;85:539-545 (Pubitemid 47531739)
23. Bochaton-Piallat ML, Kapetanios AD, Donati G, et al. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 2000;41:2336-2342
24. Kauffmann DJ, van Meurs JC, Mertens DA, et al. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35:900-906
25. Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994;35:3649-3663